AU2003235538A1 - Induction method for cell differentiation - Google Patents
Induction method for cell differentiationInfo
- Publication number
- AU2003235538A1 AU2003235538A1 AU2003235538A AU2003235538A AU2003235538A1 AU 2003235538 A1 AU2003235538 A1 AU 2003235538A1 AU 2003235538 A AU2003235538 A AU 2003235538A AU 2003235538 A AU2003235538 A AU 2003235538A AU 2003235538 A1 AU2003235538 A1 AU 2003235538A1
- Authority
- AU
- Australia
- Prior art keywords
- group
- cooh
- cell differentiation
- hydrocarbyl substituted
- membered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000024245 cell differentiation Effects 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 230000006698 induction Effects 0.000 title 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 4
- 125000004442 acylamino group Chemical group 0.000 abstract 3
- 125000000623 heterocyclic group Chemical group 0.000 abstract 3
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 2
- 230000001939 inductive effect Effects 0.000 abstract 2
- 210000002780 melanosome Anatomy 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- KZIMLUFVKJLCCH-UHFFFAOYSA-N 5-[2-(1h-imidazol-5-yl)ethylamino]-5-oxopentanoic acid Chemical compound OC(=O)CCCC(=O)NCCC1=CNC=N1 KZIMLUFVKJLCCH-UHFFFAOYSA-N 0.000 abstract 1
- 241000699660 Mus musculus Species 0.000 abstract 1
- 125000003368 amide group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- -1 cyclic imide Chemical class 0.000 abstract 1
- 239000000824 cytostatic agent Substances 0.000 abstract 1
- 230000001085 cytostatic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000003304 gavage Methods 0.000 abstract 1
- 239000000411 inducer Substances 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 201000001441 melanoma Diseases 0.000 abstract 1
- 238000011580 nude mouse model Methods 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2002105392/14A RU2217196C2 (ru) | 2002-02-28 | 2002-02-28 | Способ индукции дифференцировки клеток |
| RU2002105392 | 2002-02-28 | ||
| PCT/RU2003/000072 WO2003072124A1 (en) | 2002-02-28 | 2003-02-28 | Induction method for cell differentiation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003235538A1 true AU2003235538A1 (en) | 2003-09-09 |
Family
ID=27764932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003235538A Abandoned AU2003235538A1 (en) | 2002-02-28 | 2003-02-28 | Induction method for cell differentiation |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7759313B2 (enExample) |
| EP (1) | EP1491206B9 (enExample) |
| JP (1) | JP4711626B2 (enExample) |
| CN (1) | CN1649612B (enExample) |
| AT (1) | ATE488234T1 (enExample) |
| AU (1) | AU2003235538A1 (enExample) |
| CY (1) | CY1111265T1 (enExample) |
| DE (1) | DE60334978D1 (enExample) |
| DK (1) | DK1491206T3 (enExample) |
| EA (1) | EA007474B1 (enExample) |
| ES (1) | ES2356308T3 (enExample) |
| HK (1) | HK1079990B (enExample) |
| IL (3) | IL163763A0 (enExample) |
| PT (1) | PT1491206E (enExample) |
| RU (1) | RU2217196C2 (enExample) |
| SI (1) | SI1491206T1 (enExample) |
| UA (1) | UA85039C2 (enExample) |
| WO (1) | WO2003072124A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MC200060A1 (fr) * | 2002-10-04 | 2003-05-28 | M Exsymol Sa | Produit de couplage entre la tryptamine et un alpha-aminoacide son procédé de préparation et son application dans le domaine de la neuro-cosmétique |
| RU2335495C2 (ru) * | 2005-06-15 | 2008-10-10 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | N-ацильные производные аминокислот, их фармацевтически приемлевые соли, фармацевтическая композиция и применение в качестве гиполипидемических средств |
| RU2378284C2 (ru) * | 2008-02-13 | 2010-01-10 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Способы получения n-ацильных производных аминокислот (варианты) |
| RU2406727C2 (ru) * | 2008-02-13 | 2010-12-20 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Фармацевтическая композиция, содержащая n-ацильные производные аминокислот, и их применение в качестве противоаллергических, антианафилактических и противовоспалительных средств |
| RU2359030C1 (ru) * | 2008-03-19 | 2009-06-20 | Общество С Ограниченной Ответственностью "Лаборатория Клеточных Технологий" | Способ получения эндотелиальных клеток из эмбриональных стволовых клеток человека (варианты) |
| RU2373934C1 (ru) | 2008-03-19 | 2009-11-27 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств |
| JP5370957B2 (ja) * | 2008-08-20 | 2013-12-18 | 学校法人日本大学 | アポトーシス抑制剤 |
| CN104257515B (zh) * | 2010-10-22 | 2017-05-03 | 新钰生技股份有限公司 | 具有抑制黑色素生成的甘胺酸衍生物及使用其的美白组成物 |
| US20130195782A1 (en) * | 2010-10-22 | 2013-08-01 | Corum Inc. | Novel Glycine Derivative Capable Of Inhibiting Melanin Formation And Composition Using The Same |
| UA115431C2 (uk) * | 2011-10-11 | 2017-11-10 | Общєство С Огранічєнной Отвєтствєнностью "Валєнта-Інтєллєкт" | Застосування глутарилгістаміну для лікування захворювань дихальних шляхів |
| CN103382179A (zh) * | 2013-06-05 | 2013-11-06 | 四川百利药业有限责任公司 | 英加韦林的多晶型物及其制备方法 |
| RU2628800C2 (ru) * | 2014-03-12 | 2017-08-22 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Амидные соединения, способы получения, применение в качестве средств для лечения и профилактики заболеваний, вызываемых рнк-содержащими вирусами |
| JP7531918B2 (ja) * | 2018-09-25 | 2024-08-13 | ミエロ セラピューティクス ゲーエムベーハー | 致死的な放射線への曝露に関連する症状の治療における使用のためのイミダゾリルエタンアミドペンタン二酸 |
| RU2726119C1 (ru) * | 2019-11-22 | 2020-07-09 | Общество С Ограниченной Ответственностью "Валента - Интеллект" | Новые производные полиолов, их применение, фармацевтическая композиция на их основе |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6016934A (ja) | 1983-07-06 | 1985-01-28 | Kaneshiro Nagai | 抗腫瘍剤 |
| JPS6016926A (ja) * | 1983-07-06 | 1985-01-28 | Kaneshiro Nagai | 抗腫瘍剤 |
| US4816442A (en) * | 1986-11-07 | 1989-03-28 | Collagen Corporation | Method of inhibiting tumor growth sensitive to CIF-βtreatment |
| JPS6442430A (en) | 1987-08-11 | 1989-02-14 | Nippon Univ | Side effect remover for chemotherapeutic agent |
| US5350836A (en) * | 1989-10-12 | 1994-09-27 | Ohio University | Growth hormone antagonists |
| JPH0585942A (ja) | 1991-02-26 | 1993-04-06 | Denki Kagaku Kogyo Kk | インターフエロン−ヒアルロン酸及び／又はその塩の結合体 |
| MY128261A (en) * | 1992-10-27 | 2007-01-31 | Merck Sharp & Dohme | New substituted azetidinones as anti-inflammatory and antidegenerative agents |
| GB9308695D0 (en) * | 1993-04-27 | 1993-06-09 | Celltech Ltd | Peptidyl derivatives |
| IL110296A (en) * | 1993-07-16 | 1999-12-31 | Smithkline Beecham Corp | Imidazole compounds process for their preparation and pharmaceutical compositions containing them |
| WO1995011699A1 (en) | 1993-10-29 | 1995-05-04 | The Trustees Of Boston University | Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents |
| JP3517274B2 (ja) | 1994-05-20 | 2004-04-12 | 株式会社ナリス化粧品 | 皮膚組成物 |
| RU2120298C1 (ru) * | 1995-11-28 | 1998-10-20 | Товарищество с ограниченной ответственностью "Верта" | Иммуностимулятор и препарат на его основе |
| FR2762315B1 (fr) * | 1997-04-22 | 1999-05-28 | Logeais Labor Jacques | Derives d'amino-acides inhibiteurs des metalloproteases de la matrice extracellulaire et de la liberation du tnf alpha |
| RU2141483C1 (ru) | 1997-07-04 | 1999-11-20 | Небольсин Владимир Евгеньевич | Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция |
| EP1028745B1 (en) | 1997-11-07 | 2009-01-07 | Mayo Foundation For Medical Education And Research | Low-dose interferon immunotherapy |
| US6838436B1 (en) * | 1998-07-10 | 2005-01-04 | Osteoscreen Inc. | Inhibitors of proteasomal activity for stimulating bone growth |
| AU768269B2 (en) | 1998-10-02 | 2003-12-04 | Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The | Apoptosis inducing agents and methods |
-
2002
- 2002-02-28 RU RU2002105392/14A patent/RU2217196C2/ru not_active IP Right Cessation
-
2003
- 2003-02-28 AU AU2003235538A patent/AU2003235538A1/en not_active Abandoned
- 2003-02-28 HK HK06100072.5A patent/HK1079990B/zh not_active IP Right Cessation
- 2003-02-28 DE DE60334978T patent/DE60334978D1/de not_active Expired - Lifetime
- 2003-02-28 WO PCT/RU2003/000072 patent/WO2003072124A1/ru not_active Ceased
- 2003-02-28 IL IL16376303A patent/IL163763A0/xx unknown
- 2003-02-28 EA EA200401105A patent/EA007474B1/ru unknown
- 2003-02-28 CN CN038094959A patent/CN1649612B/zh not_active Expired - Lifetime
- 2003-02-28 US US10/505,976 patent/US7759313B2/en not_active Expired - Lifetime
- 2003-02-28 AT AT03743087T patent/ATE488234T1/de active
- 2003-02-28 PT PT03743087T patent/PT1491206E/pt unknown
- 2003-02-28 UA UA20040907835A patent/UA85039C2/uk unknown
- 2003-02-28 ES ES03743087T patent/ES2356308T3/es not_active Expired - Lifetime
- 2003-02-28 SI SI200331938T patent/SI1491206T1/sl unknown
- 2003-02-28 DK DK03743087.3T patent/DK1491206T3/da active
- 2003-02-28 JP JP2003570868A patent/JP4711626B2/ja not_active Expired - Lifetime
- 2003-02-28 EP EP03743087A patent/EP1491206B9/en not_active Expired - Lifetime
-
2004
- 2004-08-26 IL IL163763A patent/IL163763A/en active IP Right Grant
-
2010
- 2010-11-30 IL IL209653A patent/IL209653A0/en unknown
-
2011
- 2011-02-09 CY CY20111100154T patent/CY1111265T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005532269A (ja) | 2005-10-27 |
| CN1649612B (zh) | 2011-04-06 |
| EP1491206B9 (en) | 2011-03-09 |
| RU2217196C2 (ru) | 2003-11-27 |
| UA85039C2 (uk) | 2008-12-25 |
| IL163763A (en) | 2011-12-29 |
| ATE488234T1 (de) | 2010-12-15 |
| US20050180953A1 (en) | 2005-08-18 |
| CN1649612A (zh) | 2005-08-03 |
| HK1079990B (zh) | 2011-12-09 |
| SI1491206T1 (sl) | 2011-03-31 |
| US7759313B2 (en) | 2010-07-20 |
| CY1111265T1 (el) | 2015-08-05 |
| EA200401105A1 (ru) | 2004-12-30 |
| IL209653A0 (en) | 2011-02-28 |
| WO2003072124A1 (en) | 2003-09-04 |
| IL163763A0 (en) | 2005-12-18 |
| EA007474B1 (ru) | 2006-10-27 |
| PT1491206E (pt) | 2011-02-11 |
| EP1491206B1 (en) | 2010-11-17 |
| DK1491206T3 (da) | 2011-03-14 |
| EP1491206A4 (en) | 2006-01-11 |
| HK1079990A1 (en) | 2006-04-21 |
| ES2356308T3 (es) | 2011-04-06 |
| JP4711626B2 (ja) | 2011-06-29 |
| EP1491206A1 (en) | 2004-12-29 |
| DE60334978D1 (de) | 2010-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL209653A0 (en) | Peptide derivatives | |
| DE122011100032I1 (de) | Verwendung von n-substituierten pyridonen als tumornekrose-faktor alpha hemmer. | |
| TW332201B (en) | 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives | |
| NZ330216A (en) | Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and use in treatment of atherosclerosis | |
| PL322619A1 (en) | Pharmaceutic composition containing the proton-pump inhibitors | |
| ATE204583T1 (de) | Menschliche monocyte chemoattractantia proteine-1 (mcp) derivaten | |
| AU7562496A (en) | Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids | |
| DK1077691T3 (da) | Gammaaminosmörsyre-derivater indeholdende faste sammensætninger og fremgangsmåde til fremstilling heraf | |
| ATE260658T1 (de) | Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen | |
| RU2002120462A (ru) | Замещенные производные N-бензилиндол-3-ил-глиоксиловой кислоты, обладающие противоопухолевым действием (варианты), их кислотно-аддитивные соли и их применение (варианты), фармацевтический препарат, лекарственная форма | |
| EA200100791A1 (ru) | Ингибиторы аминотрансфераз, зависимых от аминокислот с разветвленной цепью, и их применение в лечении диабетической ретинопатии | |
| NO923911L (no) | Nye 17beta-substituerte aza-androstan derivater | |
| PT1039900E (pt) | Agentes terapeuticos | |
| MX9706689A (es) | Tratamiento de trastornos causados por el factor de crecimiento de citocina. | |
| ZA958023B (en) | Quinoxaline derivatives useful in therapy | |
| NO894720L (no) | Farmasoeytisk aktivt protein. | |
| DK628388D0 (da) | Vincristinholdigt produkt | |
| MX9710257A (es) | Azepanes novedosos y sus homologos de anillo para terapia y profilaxis de enfermedades mediadas por proteina cinasa. | |
| IT1256699B (it) | Sali dell'estere metossimetilico della anfotericina b. | |
| MX9605153A (es) | Agentes farmaceuticos para el tratamiento de enfermedades inflamatorias cronicas y agudas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |